Skip to Main Content

Paper Details

Correction: HDAC6 inhibitor WT161 downregulates growth factor receptors in breast cancer.
Oncotarget
0
2021
HDAC6, breast cancer, growth factor receptors
Author NameAffiliation
Jun QiDana-Farber Cancer Institute and Harvard Medical School
James E BradnerDana-Farber Cancer Institute and Harvard Medical School
James E BradnerNovartis Institutes for BioMedical Research
Kenneth C AndersonDana-Farber Cancer Institute and Harvard Medical School
Kenneth C AndersonDana-Farber Cancer Institute and Harvard Medical School
  • 1 - 5

Datasets

Release 1.2